Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Roche Warns Of Bigger Negative Impact From COVID-19 And Biosimilars

Jul 23 2020

• By Jessica Merrill

Dog in headwind at the stony beach — Roche faced headwinds from COVID-19 and biosimilars in H1 • Source: Shutterstock

Related Content

Wave Of Launches Boosts US Biosimilars Market

Apr 08 2020

BioMarin Prepares To Launch Roctavian For Hemophilia In An Uncertain Environment

Apr 30 2020

US FDA Extends Roche’s Risdiplam Decision Date

Apr 08 2020

Roche/Spark Deal Clears FTC In A Sigh Of Relief For Pharma Dealmakers

Dec 17 2019

Related Companies

Roche Holding AG

Pfizer Inc.

Amgen, Inc.

Viatris Inc.

Teva Pharmaceutical Industries Ltd.

Biogen, Inc.

Novartis AG

Spark Therapeutics, Inc.

BioMarin Pharmaceutical Inc.

Additional Topics

Sales & Earnings Biosimilars Business Strategies Commercial BioPharmaceutical

More from Earnings

More from Business

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window